This course is part of PrimaryCareNOW: Live on December 11-13, 2024.
Man holding his neck while sitting on a couch

Virtual CME Program

4.00 CME/CE Credit

P.A.C.T. Update: Practical Approaches to Comprehensive Treatment of Pain 2024-2025

The nation is currently grappling with two major public health challenges: managing acute and chronic pain in a vast number of Americans and addressing the crisis of prescription opioid abuse. Pri-Med’s P.A.C.T. Update: Practical Approaches to Comprehensive Treatment of Pain 2024-2025 curriculum is designed to equip practitioners with the skills and knowledge needed to navigate these issues effectively. This is a comprehensive pain management education focusing on improving pain management skills, risk reduction strategies, identifying opioid dependence, abuse, and misuse and more! Join this all-inclusive educational activity to enhance your clinical practice and improve patient outcomes in the context of today's complex public health landscape. This activity is also designed to help you meet the Drug Enforcement Administration (DEA) CME requirements for the MATE Act.

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.

Please see https://www.opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies.
This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).

Begin

CME/CE Information

4.00 AMA PRA Category 1 Credits™, 4.00 ABIM MOC or 4.00 AANP, including 1.38 AANP Pharm

Release Date: 12/11/2024

Expiration Date: 12/11/2024

Topics

Faculty

Learning Objectives

  • Discuss the definitions and mechanisms of pain
  • Identify risk factors and stratification for opioid-related aberrant behavior and opioid use disorder as part of the initial assessment
  • Apply individualized recommendations for nonpharmacologic and non-opioid treatment options for patients in pain
  • Review general characteristics of opioid analgesics including their intended use and risks
  • Differentiate among tolerance, physical dependence, and manifestations of opioid use disorder
  • Recognize best practices to reduce the risks associated with prescription of opioid analgesics, including safe storage and disposal
  • Anticipate and manage adverse effects of opioid use including signs of opioid overdose and the use of naloxone
  • Select approaches to safely initiate opioids for the treatment of acute pain and chronic pain
  • Identify strategies for ongoing safe and effective use of opioids in patients with chronic pain, including titration, referral, and discontinuation, when appropriate
  • Summarize counseling strategies for caregivers and patients on opioid therapy
  • Act appropriately to evaluate, treat, or refer patients with opioid use disorder
     

State Licensure Requirements

This activity satisfies topic-specific CME/CE requirements (pain management, controlled substances, etc.) of many state licensing boards. Please check with your state’s licensing boards for specific requirements, and print this page as appropriate for documentation. For more information, visit https://www.pri-med.com/state/state-mandated 

Alabama: This activity is approved for Controlled Substance Prescribing Practices, Recognizing Signs of Abuse or Misuse of Controlled Substances, or Prescribing for Pain Management by the Alabama Board of Medical Examiners & Medical Licensure Commission

Iowa: This activity is designed to satisfy requirements of ARNPs, for CE regarding the US Centers for Disease Control and Prevention Guideline for prescribing opioids for chronic pain. Please print this page as documentation, for submission with your CE certificate.

Kentucky: This activity is approved for Addiction Medicine by the Kentucky Board of Medical Licensure, ID# 0924-H4.0-PMI9a. This activity is approved for HB1/Prescribing Controlled Substances and 201 KAR 9:270 Addiction Medicine (MD/PA) by the Kentucky Board of Medical Licensure, ID# 0924-H4.0-PMI9a

New Mexico: This activity is approved for Continuing Education for the Prescribing of Controlled Substances by the New Mexico Medical Board.

Texas: This activity is approved for Pain Management and Prescription of Opioids requirements from the Texas Medical Board/Board of Nursing, as well as Medical Ethics and/or Professional Responsibility.

Utah: This activity is approved to fulfill the Utah Requirement under Utah Code 58-37-6.5 by the Utah Division of Professional Licensing

This activity satisfies training requirements for the MATE Act, which requires all DEA-registered practitioners to complete 8 hours of CME/CE credit on opioid or other substance use disorders. 

 

Faculty

Charles E. Argoff, MD, FABPM

Vice Chair
Professor of Neurology and Urology 
Albany Medical College
Director, Comprehensive Pain Center
Director, Pain Management Fellowship
Albany Medical Center
Albany, New York

Learn More

Oscar A. de Leon-Casasola, MD

Professor of Anesthesiology and Medicine 
Senior Vice-Chair 
School of Medicine and Biomedical Sciences
University at Buffalo 
Chief, Pain Medicine and Professor of Oncology 
Roswell Park Cancer Institute
Buffalo, New York

Learn More

Katherine E. Galluzzi, DO, CMD, FACOFP

Professor and Chair
Department of Geriatric and Palliative Medicine
Director, Comprehensive Care
Philadelphia College of Osteopathic Medicine
Philadelphia, Pennsylvania

Learn More

Aubrey J. Grant, MD, FACC

Sports Cardiologist, MedStar Health and Georgetown University
Founder and CEO, Equity Commons
Team Cardiologist, Baltimore Ravens, Baltimore Orioles, Washington Capitals
Member, Diversity and Inclusion Committee, American College of Cardiology

Learn More

Disclosures

The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.

Aubrey J. Grant MD, FACC: No relevant financial relationships disclosed.

Charles E. Argoff, MD, FABPM: Speaker: AbbVie, Averitas Pharma, Impel, Kowa Pharmaceuticals, Lilly, Lundbeck, Nevro, Scilex, Teva; Researcher: Abbvie; Consultant: Collegium, Nevro, Pain Scripts, Scilex, Tris, Vertex, Xgene Pharma; Stockholder: Pfizer and Trevana; Investigator: Lundbeck and Teva.

Katherine E. Galluzzi, DO, CMD, FACOFP: No relevant financial relationships disclosed.

Oscar A. de Leon-Casasola, MD: Consultant: Merck Pharmaceuticals, Vertex Pharmaceuticals.

Ty Gluckman, MD (Moderator): Consultant: OptumRX

Non-faculty contributors and others involved in the planning, development, editing, and review of the content have disclosed no relevant financial relationships.

 

CME/CE Information

AMA PRA Category 1 Credits™

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Pri-Med Institute, Equity Commons, and Miller Medical Communications. Pri-Med Institute is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Pri-Med Institute designates this live activity for a maximum of 4.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AANP

Accreditation Statement

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners® (AANP) through the joint providership of Pri-Med Institute, Equity Commons, and Miller Medical Communications. Pri-Med Institute is accredited by the AANP as an approved provider of nurse practitioner continuing education. Provider Number 040308.

Designation Statement

This activity is approved for 4.00 contact hour of continuing education, which includes 1.38 hours of pharmacology.

MOC Credit Information

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.00 MOC points and Patient Safety MOC credit in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Pri-Med Institute reports completion information to ACCME on a monthly basis, in the first week of each month. Pri-Med Institute reports completion information to ACCME on a monthly basis, in the first week of each month.



Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, P.A.C.T Update: Practical Approaches to Comprehensive Treatment of Pain 2024-2025 has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

Lifelong Learning CME Activity

Anesthesiology

Family Medicine

Physical Medicine and Rehabilitation

Preventive Medicine

Psychiatry and Neurology

Radiology

MIPS

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).

For guidance on how clinicians can attest to participation in a MIPS Improvement Activity, visit https://qpp.cms.gov/mips/improvement-activities

mips logo

Instructions for Obtaining Credit

Once you have completed the activity, please click the "next" button to advance to the post-activity assessment. To complete this activity and claim credit, you must answer 9 out of the 11 questions correctly. If you are not successful after your first attempt, you will be given an opportunity to reflect upon the answer rationales and have the opportunity to review the educational content before proceeding. Once you have selected your answers, click the "submit" button to complete the evaluation questions and proceed to the claim credit screen. For PAs, the NCCPA accepts for Category 1 CME credit activities designated for AMA PRA Category 1 Credit.

Supported by

Opioid Analgesic REMS Program Companies

Education Partners

Miller Medical Communications, LLC

Equity Commons

Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.

P.A.C.T. Update: Practical Approaches to Comprehensive Treatment of Pain 2024-2025

Begin